Common use of Registration under the Exchange Act and Stock Exchange Listing Clause in Contracts

Registration under the Exchange Act and Stock Exchange Listing. The Company has filed with the Commission a Form 8-A12B (File Number 001-________), as amended, providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock. The registration of the Securities under the Exchange Act is effective. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are listed on The NASDAQ Capital Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing except as described in the Registration Statement and Prospectus.

Appears in 4 contracts

Samples: Underwriting Agreement (Ideal Power Inc.), Underwriting Agreement (Ideal Power Inc.), Underwriting Agreement (Ideal Power Inc.)

AutoNDA by SimpleDocs

Registration under the Exchange Act and Stock Exchange Listing. In connection with its listing of the Common Stock on The NASDAQ Capital Market (“NASDAQ”), the Company has filed with the Commission a Form 8-A12B (File Number 001-___000-_____), as amended, providing for the registration of the Common Stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), . The Common Stock of the Common Stock. The registration of the Securities Company was registered under the Exchange Act is effectiveon a Registration Statement on Form 10 (File Number 54020). The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are listed on The NASDAQ Capital Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from Nasdaq, NASDAQ nor has the Company received any notification that the Commission or Nasdaq NASDAQ is contemplating terminating such registration or listing except as described in the Registration Statement Statement, the Statutory Prospectus and the Prospectus.

Appears in 2 contracts

Samples: Underwriting Agreement (Parametric Sound Corp), Underwriting Agreement (Parametric Sound Corp)

Registration under the Exchange Act and Stock Exchange Listing. The Company has filed with the Commission a Form 8-A12B (File Number 001-________001-37744), as amended, providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock. The registration of the Securities under the Exchange Act is effective. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are is listed on The NASDAQ Capital Market (“NasdaqNASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from NasdaqNASDAQ, nor has the Company received any notification that the Commission or Nasdaq NASDAQ is contemplating terminating such registration or listing except as described in the Registration Statement and Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Pulse Biosciences, Inc.)

Registration under the Exchange Act and Stock Exchange Listing. The Company has filed with the Commission a Form 8-A12B (File Number 001-___000-_____), as amended, providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock. The registration of the Securities under the Exchange Act is effective. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are is listed on The NASDAQ Capital Market (“NasdaqNASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from NasdaqNASDAQ, nor has the Company received any notification that the Commission or Nasdaq NASDAQ is contemplating terminating such registration or listing except as described in the Registration Statement and Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Second Sight Medical Products Inc)

Registration under the Exchange Act and Stock Exchange Listing. In connection with its listing of the Common Stock on The NASDAQ Capital Market (“NASDAQ”), the Company has filed with the Commission a Form 8-A12B (File Number 001-________001-35465), as amended, providing for the registration of the Common Stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), . The Common Stock of the Common Stock. The registration of the Securities Company was registered under the Exchange Act is effectiveon a Registration Statement on Form 10 (File Number 54020). The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are listed on The NASDAQ Capital Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from Nasdaq, NASDAQ nor has the Company received any notification that the Commission or Nasdaq NASDAQ is contemplating terminating such registration or listing except as described in the Registration Statement Statement, the Statutory Prospectus and the Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Parametric Sound Corp)

Registration under the Exchange Act and Stock Exchange Listing. The Company has filed with the Commission a Form 8-A12B (File Number 001-________000- ), as amended, providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock. The registration of the Securities under the Exchange Act is effective. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are is listed on The NASDAQ Capital Market (“NasdaqNASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from NasdaqNASDAQ, nor has the Company received any notification that the Commission or Nasdaq NASDAQ is contemplating terminating such registration or listing except as described in the Registration Statement and Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Pulse Biosciences, Inc.)

Registration under the Exchange Act and Stock Exchange Listing. The Company has filed with the Commission a Form 8-A12B (File Number 001-___000-_____), as amended, providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock. The registration of the Securities under the Exchange Act is effective. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are listed on The NASDAQ Capital Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing except as described in the Registration Statement and Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Energous Corp)

AutoNDA by SimpleDocs

Registration under the Exchange Act and Stock Exchange Listing. The Company has filed with the Commission a Form 8-A12B (File Number 001-________[●]), as amended, providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock. The registration of the Securities Shares under the Exchange Act is effective. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are is listed on The NASDAQ Capital Market (“NasdaqNASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from NasdaqNASDAQ, nor has the Company received any notification that the Commission or Nasdaq NASDAQ is contemplating terminating such registration or listing except as described in the Registration Statement and Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Cue Biopharma, Inc.)

Registration under the Exchange Act and Stock Exchange Listing. The Company has filed with the Commission a Form 8-A12B (File Number 001-___000-_____), as amended, providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock. The registration of the Securities under the Exchange Act is effective. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are listed on The the NASDAQ Capital Market (“NasdaqNASDAQ”), and the . The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from NasdaqNASDAQ, nor has the Company received any notification that the Commission or Nasdaq NASDAQ is contemplating terminating such registration or listing except as described in the Registration Statement and Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Imprimis Pharmaceuticals, Inc.)

Registration under the Exchange Act and Stock Exchange Listing. The Company has filed with the Commission a Form 8-A12B (File Number 001-________001-35814), as amended, providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock. The registration of the Securities under the Exchange Act is effective. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are is listed on The the NASDAQ Capital Market (“NasdaqNASDAQ”), and the . The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from NasdaqNASDAQ, nor has the Company received any notification that the Commission or Nasdaq NASDAQ is contemplating terminating such registration or listing except as described in the Registration Statement and Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Imprimis Pharmaceuticals, Inc.)

Registration under the Exchange Act and Stock Exchange Listing. The Company has filed with the Commission a Form 8-A12B (File Number 001-________001-35521), as amended, providing for the registration under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the Common Stock. The registration of the Securities under the Exchange Act is effective. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and are listed on The NASDAQ Capital Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing except as described in the Registration Statement and Prospectus.

Appears in 1 contract

Samples: Underwriting Agreement (Clearsign Combustion Corp)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!